Tankyrase-1 mRNA expression in bladder cancer and paired urine sediment: Preliminary experience

Clinical Chemistry and Laboratory Medicine

Volumn 45, Issue 7, 2007, Pages 862-866

  Gelmini, Stefania ^a   Quattrone, Silvia ^a   Malentacchi, Francesca ^a   Villari, Donata ^a   Travaglini, Fabrizio ^a   Giannarini, Gianluca ^b   Della Melina, Alessandro ^a   Pazzagli, Mario ^a   Nicita, Giulio ^a   Selli, Cesare ^b   Orlando, Claudio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Bladder cancer; hTERT; Real time RT PCR; Recurrence; Tankyrase; Telomere; Voided urine

Indexed keywords

MESSENGER RNA; TANKYRASE;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER CARCINOMA; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; MALE; MUCOSA; NUCLEOTIDE SEQUENCE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SENSITIVITY ANALYSIS; TISSUE SECTION; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; URINE SEDIMENT;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RNA, MESSENGER; TANKYRASES; TELOMERE; URINARY BLADDER NEOPLASMS;

EID: 34447249487     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2007.133     Document Type: Article

References (26)

1. Shay JW, Zou Y, Hiyama E, Wright WE. Telomerase and cancer. Hum Mol Genet 2001;10:677-85.
2. Moyzis RK, Buckingham JM, Cram LS, Dani M, Deaven LL, Jones MD, et al. A highly conserved repetitive DNA sequence (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 1998;85:6622-6.
3. Zakian VA. Telomeres: beginning to understand the end. Science 1995;270:1601-7.
4. Rhyu MS. Telomeres, telomerase, and immortality. J Natl Cancer Inst 1995;87:884-94.
5. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-5.
6. Lustig AJ. Crisis intervention: the role of telomerase. Proc Natl Acad Sci USA 1999;96:3339-41.
7. Smogorzewska A, de Lange T. Regulation of telomerase by telomeric proteins. Annu Rev Biochem 2004;73:177-208.
8. Gertler R, Rosenberg R, Stricker D, Friederichs J, Hoos A, Werner M, et al. Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma. J Clin Oncol 2004;22:1807-14.
9. Cong YS, Wright WE, Shay JW. Human telomerase and its regulation. Microbiol Mol Biol Rev 2002;66:407-25.
10. Smith S, Giriat I, Schmitt A, de Lange T. Tankyrase, a poly(ADP-ribose) polymerase at human telomeres. Science 1998;282:1484-7.
11. Bilaud T, Brun C, Ancelin K, Koering CE, Laroche T, Gilson E. Telomeric localization of TRF2, a novel human telobox protein. Nat Genet 1997;17:236-9.
12. van Steensel B, de Lange T. Control of telomere length by the human telomeric protein TRF1. Nature 1997;385:740-3.
13. Smogorzewska A, van Steensel B, Bianchi A, Oelmann S, Schaefer MR, Schnapp G, et al. Control of human telomere length by TRF1 and TRF2. Mol Cell Biol 2000;20:1659-68.
14. Karlseder J, Smogorzewska A, de Lange T. Senescence induced by altered telomere state, not telomere loss. Science 2002;295:2446-9.
15. Smith S, de Lange T. Tankyrase promotes telomere elongation in human cells. Curr Biol 2000;10:1299-1302.
16. Xu D, Zheng C, Bergenbrant S, Holm G, Bjorkholm M, Yi Q, et al. Telomerase activity in plasma cell dyscrasias. Br J Cancer 2001;84:621-5.
17. MacNamara B, Wang W, Chen Z, Hou M, Mazur J, Gruber A, et al. Telomerase activity in relation to pro- and anti-apoptotic protein expression in high grade non-Hodgkin's lymphomas. Haematologica 2001;86:386-93.
18. Gelmini S, Poggesi M, Distante V, Bianchi S, Simi L, Luconi M, et al. Tankyrase, a positive regulator of telomere elongation, is over expressed in human breast cancer. Cancer Lett 2004;216:81-7.
19. Gelmini S, Poggesi M, Pinzani P, Mannurita SC, Cianchi F, Valanzano R, et al. Distribution of tankyrase-1 mRNA expression in colon cancer and its prospective correlation with progression stage. Oncol Rep 2006;16:1261-6.
20. van Rhijn BW, van der Poel HG, van der Kwast TH. Urine markers for bladder cancer surveillance: a systematic review. Eur Urol 2005;47:736-48.
21. Muller M. Telomerase: its clinical relevance in the diagnosis of bladder cancer. Oncogene 2002;21:650-5.
22. Gelmini S, Crisci A, Salvadori B, Pazzagli M, Selli C, Orlando C. Comparison of telomerase activity in bladder carcinoma and exfoliated cells collected in urine and bladder washings, using a quantitative assay. Clin Cancer Res 2000;6:2771-6.
23. Sobin LH, Wittekind C. TNM classification of malignant tumors, 6th ed. New York: Wiley-Liss, 2002.
24. Mostofi FK, Sobin LH, Torloni H. Histological typing of urinary bladder tumours. In: World Health Organization International Histological Classification of Tumours, no. 10. Geneva: World Health Organization, 1973.
25. Ohyashiki K, Yahata N, Ohyashiki JH, Iwama H, Hayashi S, Ando K, et al. A combination of semiquantitative telomerase assay and in-cell telomerase activity measurement using exfoliated urothelial cells for the detection of urothelial neoplasia. Cancer 1998;83:2554-60.
26. Kyo S, Kunimi K, Uchibayashi T, Namiki M, Inoue M. Telomerase activity in human urothelial tumors. Am J Clin Pathol 1997;107:555-60.